Manuscript

High p95HER2/HER2 ratio associated with poor outcome in Trastuzumab-treated HER2-positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

March 1, 2018

Download

Jeff Sperinde
Weidong Huang
Aki Vehtari
Ahmed Chenna
Pirkko-Liisa Kellokumpu-Lehtinen
John Winslow
Petri Bono
Yolanda S. Lie
Christos J. Petropoulos
Jodi Weidler
and Heikki Joensuu

Cancers & tumors Biomarkers Clinical Cancer Research Oncology